BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20851135)

  • 1. DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer.
    Samuelsson JK; Alonso S; Yamamoto F; Perucho M
    Mutat Res; 2010 Nov; 693(1-2):61-76. PubMed ID: 20851135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-Sensitive Amplification Length Polymorphism (MS-AFLP) Microarrays for Epigenetic Analysis of Human Genomes.
    Alonso S; Suzuki K; Yamamoto F; Perucho M
    Methods Mol Biol; 2018; 1766():137-156. PubMed ID: 29605851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.
    Cheng YW; Pincas H; Bacolod MD; Schemmann G; Giardina SF; Huang J; Barral S; Idrees K; Khan SA; Zeng Z; Rosenberg S; Notterman DA; Ott J; Paty P; Barany F
    Clin Cancer Res; 2008 Oct; 14(19):6005-13. PubMed ID: 18829479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome.
    Ried T; Meijer GA; Harrison DJ; Grech G; Franch-Expósito S; Briffa R; Carvalho B; Camps J
    Mol Aspects Med; 2019 Oct; 69():48-61. PubMed ID: 31365882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
    Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
    Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Somatic DNA Methylation Alterations of Genes Encoding Cell Surface Metallopeptidases in Colorectal Cancer.
    Alonso S; González B; Alibés A; Perucho M
    Methods Mol Biol; 2018; 1731():271-294. PubMed ID: 29318561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers.
    Kahlenberg MS; Stoler DL; Basik M; Petrelli NJ; Rodriguez-Bigas M; Anderson GR
    J Natl Cancer Inst; 1996 Nov; 88(22):1665-70. PubMed ID: 8931611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative DNA Methylation Profiling in Cancer.
    Ammerpohl O; Haake A; Kolarova J; Siebert R
    Methods Mol Biol; 2016; 1381():75-92. PubMed ID: 26667456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors.
    Hesson LB; Ng B; Zarzour P; Srivastava S; Kwok CT; Packham D; Nunez AC; Beck D; Ryan R; Dower A; Ford CE; Pimanda JE; Sloane MA; Hawkins NJ; Bourke MJ; Wong JW; Ward RL
    Mol Cancer Res; 2016 Dec; 14(12):1217-1228. PubMed ID: 27671336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting.
    Malkhosyan S; Yasuda J; Soto JL; Sekiya T; Yokota J; Perucho M
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10170-5. PubMed ID: 9707619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic alterations during renal carcinogenesis.
    Arai E; Kanai Y
    Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of TGCA data reveals genetic and epigenetic changes and biological function of
    Jiang Z; Wang H; Li L; Hou Z; Liu W; Zhou T; Li Y; Chen S
    Future Oncol; 2019 Dec; 15(35):4031-4043. PubMed ID: 31773991
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of genetic alterations in hereditary colorectal cancer screening.
    Pineda M; González S; Lázaro C; Blanco I; Capellá G
    Mutat Res; 2010 Nov; 693(1-2):19-31. PubMed ID: 19931546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and epigenetics in colon cancer.
    Nystrom M; Mutanen M
    World J Gastroenterol; 2009 Jan; 15(3):257-63. PubMed ID: 19140224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation and colorectal cancer.
    Matsubara N
    Dis Colon Rectum; 2012 Jan; 55(1):96-104. PubMed ID: 22156874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling and genome-wide analysis based on somatic copy number alterations in advanced colorectal cancers.
    Sugai T; Takahashi Y; Eizuka M; Sugimoto R; Fujita Y; Habano W; Otsuka K; Sasaki A; Yamamoto E; Matsumoto T; Suzuki H
    Mol Carcinog; 2018 Mar; 57(3):451-461. PubMed ID: 29230882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.
    Xie T; Cho YB; Wang K; Huang D; Hong HK; Choi YL; Ko YH; Nam DH; Jin J; Yang H; Fernandez J; Deng S; Rejto PA; Lee WY; Mao M
    Genomics; 2014 Oct; 104(4):234-41. PubMed ID: 25066378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and epigenetic instability in colorectal cancer pathogenesis.
    Grady WM; Carethers JM
    Gastroenterology; 2008 Oct; 135(4):1079-99. PubMed ID: 18773902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Epigenetic Characterization of Growth Hormone-Secreting Pituitary Tumors.
    Välimäki N; Schalin-Jäntti C; Karppinen A; Paetau A; Kivipelto L; Aaltonen LA; Karhu A
    Mol Cancer Res; 2019 Dec; 17(12):2432-2443. PubMed ID: 31578227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
    Weisenberger DJ; Liang G; Lenz HJ
    Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.